跳至主要内容
临床试验/ACTRN12610000742077
ACTRN12610000742077招募中3 期

The effect of intranasal oxytocin on cannabis and associated alcohol cravings and withdrawal in patients diagnosed with cannabis and alcohol dependence

niversity of Sydney0 个研究点目标入组 80 人开始时间: 2010年9月6日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Diagnostic and Statistical Manual for Mental Disorders-IV diagnostic criteria for cannabis and alcohol dependence.

排除标准

  • Severe depression with suicidal thoughts and/ or actions
  • Drug addiction (other than nicotine, cannabis, or alcohol)
  • Currently take medication and you are not stable on this medication (i.e., have been taking the medication for less than 4 weeks)
  • Are currently receiving psychological or pharmacological treatment for substance use problems
  • Kidney Disease- (i.e., kidney stones, recurrent bladder infections, or known kidney failure).
  • Severe liver disease (e.g., decompensated hepatic failure)
  • Sensitivity to preservatives (in particular E 216, E 218 and chlorobutanol hemihydrate).
  • Nasal obstruction, discharge, or bleeding
  • Cardiovascular problems (e.g., heart disease, history of heart attacks), high blood pressure (hypertension)
  • Habitually drink large volumes of water

研究者

相似试验